Pages that link to "Q30424413"
Jump to navigation
Jump to search
The following pages link to Prospects for treatment of latent HIV. (Q30424413):
Displayed 33 items.
- Highly significant antiviral activity of HIV-1 LTR-specific tre-recombinase in humanized mice (Q21090483) (← links)
- Enhancing Human Immunodeficiency Virus-Specific CD8(+) T Cell Responses with Heteroclitic Peptides (Q26800123) (← links)
- Emerging strategies to deplete the HIV reservoir (Q27023877) (← links)
- Bioinformatics and HIV latency (Q28081427) (← links)
- Latency reversal and viral clearance to cure HIV-1. (Q30248766) (← links)
- Developments in HIV-1 immunotherapy and therapeutic vaccination. (Q30364312) (← links)
- Benzotriazoles Reactivate Latent HIV-1 through Inactivation of STAT5 SUMOylation. (Q33771155) (← links)
- Designed transcription activator-like effector proteins efficiently induced the expression of latent HIV-1 in latently infected cells (Q34870253) (← links)
- Choice of antiretroviral therapy differentially impacts survival of HIV-infected CD4 T cells (Q35111879) (← links)
- Eradicating HIV-1 infection: seeking to clear a persistent pathogen (Q35252186) (← links)
- Whole-body immunoPET reveals active SIV dynamics in viremic and antiretroviral therapy-treated macaques (Q35586914) (← links)
- Expanded cytotoxic T-cell lymphocytes target the latent HIV reservoir (Q35812943) (← links)
- Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies (Q36148964) (← links)
- FACT Proteins, SUPT16H and SSRP1, Are Transcriptional Suppressors of HIV-1 and HTLV-1 That Facilitate Viral Latency (Q36283854) (← links)
- The immunology of human cytomegalovirus latency: could latent infection be cleared by novel immunotherapeutic strategies? (Q36302615) (← links)
- Therapy for latent HIV-1 infection: the role of histone deacetylase inhibitors (Q37626634) (← links)
- Progress in HIV-1 Integrase Inhibitors: A Review of their Chemical Structure Diversity (Q37651096) (← links)
- Chemokine receptor modeling: an interdisciplinary approach to drug design (Q38172960) (← links)
- HIV-1 latency: an update of molecular mechanisms and therapeutic strategies (Q38204866) (← links)
- Dilazep synergistically reactivates latent HIV-1 in latently infected cells (Q39148809) (← links)
- Inhibiting the HIV integration process: past, present, and the future. (Q39352071) (← links)
- Preclinical safety and efficacy of an anti-HIV-1 lentiviral vector containing a short hairpin RNA to CCR5 and the C46 fusion inhibitor (Q39600778) (← links)
- Modulation of the strength and character of HIV-specific CD8+ T cell responses with heteroclitic peptides (Q40047262) (← links)
- A chalcone derivative reactivates latent HIV-1 transcription through activating P-TEFb and promoting Tat-SEC interaction on viral promoter (Q40054870) (← links)
- HIV-1 CCR5 gene therapy will fail unless it is combined with a suicide gene. (Q40205321) (← links)
- Concise and Practical Asymmetric Synthesis of a Challenging Atropisomeric HIV Integrase Inhibitor. (Q42144330) (← links)
- Computer-aided design and discovery of protein-protein interaction inhibitors as agents for anti-HIV therapy (Q42225889) (← links)
- How Might We Cure HIV? (Q42227337) (← links)
- HIV cure: knocking on the door. (Q42266102) (← links)
- Comparative Analysis of Tat-Dependent and Tat-Deficient Natural Lentiviruses (Q43564279) (← links)
- The bromodomain and extraterminal domain inhibitor bromosporine synergistically reactivates latent HIV-1 in latently infected cells. (Q47098415) (← links)
- HIV replication and latency in a humanized NSG mouse model during suppressive oral combinational ART. (Q49990061) (← links)
- Mathematical Analysis of Viral Replication Dynamics and Antiviral Treatment Strategies: From Basic Models to Age-Based Multi-Scale Modeling (Q56000943) (← links)